Evidence map›Paper›PMID 25396061›Full record

ArticleLupus science & medicine2014

Pathogenic autoantibodies from patients with lupus nephritis cause reduced tyrosine phosphorylation of podocyte proteins, including tubulin.

Jessica J Manson, Kevin Mills, Elizabeth Jury, Lesley Mason, David P D'Cruz, Lan Ni, Moin Saleem, Peter Mathieson, David Isenberg, Anisur Rahman

Open access · goldAbstract read
In one paragraph

Article in Lupus science & medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Jessica J MansonDivision of Medicine , Centre for Rheumatology Research, University College London, Rayne Institute , London , UK.
Kevin MillsClinical and Molecular Genetics Unit , Institute for Child Health and Great Ormond Street Hospital , London , UK.
Elizabeth JuryDivision of Medicine , Centre for Rheumatology Research, University College London, Rayne Institute , London , UK.
Lesley MasonDivision of Medicine , Centre for Rheumatology Research, University College London, Rayne Institute , London , UK.
David P D'CruzLupus Research Unit , St Thomas' Hospital , London , UK.
Lan NiDepartment of Renal Medicine , University of Bristol , Bristol , UK.
Moin SaleemDepartment of Renal Medicine , University of Bristol , Bristol , UK.
Peter MathiesonDepartment of Renal Medicine , University of Bristol , Bristol , UK.
David IsenbergDivision of Medicine , Centre for Rheumatology Research, University College London, Rayne Institute , London , UK.
Anisur RahmanDivision of Medicine , Centre for Rheumatology Research, University College London, Rayne Institute , London , UK.
University College London · GBUniversity of Bristol · GBSt Thomas' Hospital · GB

Funding

Versus Arthritis 18106
6 · The paper itself

Abstract

introductionThe tertiary structure of normal podocytes prevents protein from leaking into urine. Patients with lupus nephritis (LN) develop proteinuria, and kidney biopsies from these patients display a number of podocyte abnormalities including retraction of podocyte processes. Autoantibodies have been shown to deposit in the kidneys of patients and mice with LN and are believed to play a key role in causing renal inflammation and dysfunction. The objective of this research was to study the effects of IgG antibodies from patients with LN on cultured human podocytes.

methodsWe exposed a human podocyte cell line to heat-inactivated (HI) plasma and purified polyclonal IgG from the following groups of subjects; patients with LN, patients with lupus without nephritis, patients with rheumatoid arthritis and healthy controls. We measured expression and intracellular distribution of podocyte-specific proteins and global phosphorylation of tyrosine. We then used mass spectrometry to identify the major protein targets of this phosphorylation.

resultsHI LN plasma did not alter expression or cellular distribution of podocyte-specific proteins but caused a significant reduction in podocyte protein tyrosine phosphorylation compared with plasma from healthy controls (p=0.0008). This result was replicated using purified IgG but was not seen with plasma from rheumatoid arthritis or non-renal lupus patients. The dominant tyrosine phosphorylated protein in podocytes was 55 kDa in size and was identified as tubulin.

conclusionsSince tubulin is an important component of podocyte major processes, these results suggest that autoantibodies from LN patients may exert an important pathogenic effect by dephosphorylation of this protein in podocytes.

Indexed as

nephritisphosphorylationpodocyte

Identifiers

PMID25396061
PMCPMC4225730
OpenAlexW2133903686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.